Practices

Cases Investigated

Beasley Allen is currently investigating the following cases involving unsafe medications. However, our attorneys would like to investigate any claims of serious injury or death that may be the result of defective medical devices or drugs.

Invokana clinical trial shows drug doubles risk of amputation

June 22, 2017 - Jansen reported Invokana reduced the risk of cardiovascular complications in diabetic patients, but it also doubled the number of amputations for patients taking Invokana compared to the... Read More


Talcum powder ovarian cancer trial begins in St. Louis

June 7, 2017 - The sixth talc trial against Johnson & Johnson in City of St. Louis Circuit Court started this week. Plaintiffs represent the estates of three women who died from ovarian cancer following... Read More


First bellwether trial in testosterone litigation underway in Chicago

June 6, 2017 - The first trial in multidistrict litigation (MDL) involving testosterone replacement therapy (TRT) began June 5 in the U.S. District Court for Northern Illiniois in Chicago. Read More


Second Xarelto bellwether trial underway

May 25, 2017 - The second bellwether trial involving bleeding risks with the blood thinner Xarelto is slated to begin Tuesday following the Memorial Day holiday. Read More


First MDL trial over testosterone replacement drugs set for June

May 5, 2017 - Thousands of men have suffered negative and even life-threatening side effects after taking testosterone replacement drugs and they will soon have their day in court to question the... Read More


Chemotherapy drug Taxotere lawsuits skyrocketing over permanent hair loss

April 27, 2017 - Many cancer patients who took the chemotherapy drug Taxotere are now experiencing permanent hair loss. Read More


Dexilant use linked to serious, repeated episodes of vertigo

April 20, 2017 - Dexilant and Dexilant Solutab are prescription drugs in a class of drugs known as proton pump inhibitors (PPIs). Read More


Johnson & Johnson, Janssen Pharmaceuticals legal battles over Risperdal continue

March 15, 2017 - Plaintiffs contend Janssen concealed the risk of Risperdal’s most devastating side effect, gynecomastia, or the abnormal growth of breast tissue in young boys. Read More


Bristol-Myers Squibb top-selling antipsychotic Abilify linked to users’ compulsive gambling

March 8, 2017 - When the FDA reviewed Abilify’s adverse events reports, 184 of them linked the drug with the impulse-control problems that developed in adults and children taking Abilify. The most... Read More


Lawsuits increase as research linking Proton Pump Inhibitor (PPI) heartburn drugs and kidney damage mounts

March 1, 2017 - A 1992 study first linked PPI use to Acute Interstitial Nephritis (AIN), inflammation in the spaces between the kidney tubules. Later studies linked PPI use with an increased risk of Acute... Read More


back to top